Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on BPC-157 has been registered.
- 2 registered studies in total.
- 1 is still enrolling people, so this is active research, not just history.
What kind of research
- 2 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 162 people took part in those.
How far along it is
- None have reached phase 3 — the large, late-stage trials where a drug has to prove itself before regulators will approve it.
- None have published results in the medical literature yet, so the findings are not yet open to outside scrutiny.
- The research spans 2 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 2 of 2 trials for BPC-157.
BPC 157 for Acute Hamstring Muscle Strain Repair
Hudson Biotech
Hamstring Muscle Strain · Skeletal Muscle Injury
PCO-02 - Safety and Pharmacokinetics Trial
PharmaCotherapia d.o.o.
Healthy Volunteers
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when BPC-157 is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.